Paul Jansen

Paul Jansen is currently working as a Drug Device Development Consultant. He is also on the Board of Directors at Subcuject and sits on the Advisory Boards of Evoleen, Windgap, and Kymanox.

He was formerly Associate Vice President, Medical Device Development, Sanofi until his retirement in January 2017. Jansen is a Professional Engineer with more than 30 years of experience in medical devices. He completed his degree in mechanical engineering and has completed graduate work in biomedical engineering at the University of Toronto.

Jansen has extensive experience in the design, development, manufacturing, and lifecycle management of medical devices. Jansen has multiple patents to his name and has deep experience in the creation and management of intellectual property portfolios. He has successfully led teams that have developed and launched several award-winning devices, including Lantus SoloStar, the world’s most popular insulin pen injection device. In addition, he has expertise in the design and development of injection molding systems and electronic components.

Jansen has been a long-time member of the International Standards Organization serving as Working Group Convenor and Expert on many work groups responsible for standards related to injection devices. Until January 2022, he was the Chair of Technical Committee 84, Devices for the administration of Medicinal Products and Catheters.